Purification and characterization of heparin-binding endothelial cell growth factors.

Roy R. Lobb(Biogen (Switzerland)), Michael Klagsbrun(Boston Children's Hospital), Patrìcia A. D'Amore(Massachusetts Eye and Ear Infirmary), Robert Sullivan(Boston Children's Hospital), Joachim Sasse(Brigham and Women's Hospital), J Jacobs(Brigham and Women's Hospital), Yuen Shing(Boston Children's Hospital)
Journal of Biological Chemistry
February 1, 1986
10.1016/s0021-9258(17)36031-3
Cited by 262

Related Papers

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
|Cell|1997|4.5k
Angiogenesis.
|Journal of Biological Chemistry|1992|2.7k
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor
|Cell|1991|2.4k
Oxygen-induced retinopathy in the mouse.
|PubMed|1994|1.6k
Engineering vascularized skeletal muscle tissue
|Nature Biotechnology|2005|1.3k